SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research

This letter to the editor responds to comments on a recently published article on seroconversion rates after COVID-19 vaccination.

Detalles Bibliográficos
Autores principales: Guven, Deniz C, Sahin, Taha K, Akın, Serkan, Uckun, Fatih M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632303/
https://www.ncbi.nlm.nih.gov/pubmed/36005823
http://dx.doi.org/10.1093/oncolo/oyac173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632303/
https://www.ncbi.nlm.nih.gov/pubmed/36005823
http://dx.doi.org/10.1093/oncolo/oyac173

Ejemplares similares